A cancer drug was found to be ineffective in preventing recurrence of kidney cancer in patients who recently underwent tumor removal surgery, according to a clinical trial published in the Journal of Clinical Oncology.
Apr 25, 2024
0
0
A drug that can help prevent migraines could soon be available on the NHS. Atogepant (brand name: Aquipta) was recently recommended by the National Institute for Health and Care Excellence (NICE) to prevent episodic and chronic ...
Apr 23, 2024
0
3
University of Hawaiʻi Cancer Center researchers have conducted a phase II clinical trial investigating the potential of pembrolizumab maintenance therapy, a type of immunotherapy, in aggressive forms of breast cancer. The ...
Apr 18, 2024
0
9
Protecting men who have sex with men against gonorrhea with the 4CMenB meningococcal B vaccine is cost-effective; Imperial College London study finds
Apr 17, 2024
0
0
Researchers have developed synthetic platelets that can be used to stop bleeding and enhance healing at the site of an injury. The researchers have demonstrated that the synthetic platelets work well in animal models but ...
Apr 11, 2024
0
16
Two plant compounds with potential as GLP-1 agonist weight loss pills have been identified in an AI (artificial intelligence)-based study, the European Congress on Obesity (ECO 2024) (Venice 12-15 May) will hear.
Mar 26, 2024
0
8
Patients undergoing chemotherapy often experience cognitive effects such as memory impairment and difficulty concentrating—a condition commonly known as "chemo brain."
Mar 6, 2024
0
30
Artificial Intelligence has helped scientists reveal a new form of aggressive prostate cancer that could revolutionize how the disease is diagnosed and treated in the future.
Feb 29, 2024
0
69
Auricular acupuncture, recommended by the World Health Organization (WHO) and offered as an integrative practice since 2006 by the SUS (Sistema Única de Saúde), Brazil's national health service, is safe for patients with ...
Feb 27, 2024
0
144
Even mild and moderate side effects can contribute to patients with cancer discontinuing their treatment, according to an analysis published in the Journal of Clinical Oncology.
Feb 20, 2024
0
0
